Eisenberg, R., Albert, D., Stansberry, J., Tsai, D., Kolasinski, S., & Khan, S. (2003). A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus. BioMed Central.
Chicago ZitierstilEisenberg, R., D. Albert, J. Stansberry, D. Tsai, S. Kolasinski, und S. Khan. A Phase I Trial of B-cell Depletion With Anti-CD20 Monoclonal Antibody (rituximab) in the Treatment of Systemic Lupus Erythematosus. BioMed Central, 2003.
MLA ZitierstilEisenberg, R., et al. A Phase I Trial of B-cell Depletion With Anti-CD20 Monoclonal Antibody (rituximab) in the Treatment of Systemic Lupus Erythematosus. BioMed Central, 2003.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.